Medical device tax is here to stay, says AdvaMed’s James Mazzo

*Correction Dec. 13, 2012: Mazzo is a member of AdvaMed’s board of directors and he is chairman of the nominating committee. coverage of the medical device tax

Forget "cautious optimism" – the 2.3% medical device tax isn’t going anywhere, according to Abbott Medical Optics president and former AdvaMed board chairman James Mazzo.

Speaking at MassDevice’s Big 100 Roundtable West event in Newport Beach, Calif., last night, Mazzo told an audience of device stakeholders that the medical device tax flat-out won’t be repealed despite the industry’s best efforts in D.C.

"I’m not trying to be a ‘Debbie Downer’ here," Mazzo told after the presentation. "I’m just trying to be a realist."

"We’re still going to fight this," he added. "If we can modify it, that’s a win."

Mazzo had nothing but praise for the industry’s tactics in fighting the medical device tax, but maintained that the efforts would not result in repeal of the levy, which is expected to generate $30 billion over the course of 10 years in order to help pay for healthcare reform.

"I think our tactics are outstanding – remember that we were at $60 billion, we got to $30 billion," Mazzo told us. "The question was polled to me – do I think it’s going to be repealed? It’s not because of a lack of effort or a lack of tactics or even a lack of common sense, but I have to be realistic."

Read more of’s coverage of the medical device tax.

It’s a departure from the mantra most often heard from medical device industry lobbying group AdvaMed, which as recently as last month told that the industry remains “cautiously optimistic” that they can tackle the tax before it takes effect at the start of the year, citing growing support from Democrats as well as Republicans who have publicly advocated for repeal.

Just earlier this week a group of 18 Democratic Senators wrote a joint letter to Senate Majority Leader Harry Reid (D-Nev.), calling on his to delay the implementation of the tax in efforts to "ensure that our country maintains its global leadership position in the medical technology industry and keeps good jobs here at home."

But to think that the growing bipartisan momentum against the tax will result in repeal isn’t realistic, Mazzo told us. The measure represents a "political nightmare" for lawmakers and healthcare regulators, both in finding a way to make up for the $30 billion in revenue the tax is meant to generate and in justifying a break for the medtech industry without having to cave in to other groups also tagged to help pay for healthcare reform.

"They’re seeing it as a group that was $60 billion and we negotiated $30 billion," said Mazzo, who chairs AdvaMed’s nominating committee after ceding board chairmanship to Zimmer Holdings (NYSE:ZMH) president & CEO David Dvorak earlier this year. "The next question is who’s going to supplant it? They’re going to sit there and say ‘If we lose $30 billion, we still have an issue,’ and then you’ll have other organizations say ‘Why did the device people get off?’"

Mazzo is still hopeful that the tax may be modified in ways that may lessen the impact, especially for smaller companies that will have a harder time absorbing the burden.

"Could [regulators] start to interpret that smaller companies are going to be more impacted than larger companies? Could there be a modification of the tax? Possibly," he said. "That’s why delay gives us the chance to have that interaction and that discussion."

There’s a better chance that it may be modified, and that’s where the push for a delay to implementation of the tax is key. And a delay is much more likely in Mazzo’s view.

"In 2 years some very important Senate seats are up and those senators are reading the tea leaves, so I would say that there’s a good chance [the medical device tax] is delayed," Mazzo told the audience last night. "Canceled – absolutely not. Delayed – yes."

RSS From Medical Design & Outsourcing

  • VC funding in healthcare comes in at $1.2 billion in Q2 2015
    Mercom Capital Group, a global communications and research firm, released its report on funding and mergers and acquisitions (M&A) activity for the Healthcare Information Technology (IT) and Digital Health sector for the second quarter of 2015. Mercom’s comprehensive report covers deals of all sizes across the globe. Healthcare IT VC Funding Q2 2014 to Q2 […]
  • Schneider Electric’s new motor is ideal for small spaces
    Schneider Electric presents the smallest Lexium MDrive integrated motor, 1.7 in. (42mm) NEMA size 17, which delivers a large range of features to small spaces. Features that now include an IP65 rated version with industrial M12 connectors. M12 Lexium MDrive products provide a robust interface, with IP65 certification for protection against water and dust in […]
  • Emuge expands solid carbide thread mill program with new 3XD sizes
    Emuge is now offering an expanded line of Solid Carbide Thread Mills in their popular THREADS-ALL Program, to include new 3XD sizes designed for maximum reach. A total of 17 new sizes have been added, from miniature to standard size tools, providing maximum versatility in a wide range of thread milling applications. The 3XD THREADS-ALL […]
  • Start of helpful humanoid robots? CITEC uses compact LDS component as sensor array
    Editor’s Note: LaserMicronics, a service provider for laser-based manufacturing, has released the whitepaper “Robot hand with a sensitive touch: LDS tactile sensors for sensorimotor skills.” The paper describes a 2014 project from the CITEC department at Bielefeld University in Bielefeld, Germany, where researchers created a tactile sensor resembling a human fingertip. The sensor was then […]
  • Nature meets technology: Festo’s BionicANTs cooperate to solve a common task
    Editor’s Note: Festo, an industrial control and automation company, has released the whitepaper “BionicANTs: Cooperative behavior based on a natural model.” The paper describes the BionicANT, a creation of Festo engineers that duplicates the physical anatomy of its natural counterpart and reproduces the insect’s cooperative behavior. Festo engineers have used the delicate anatomy of an […]
  • Acorn Regulatory streamlines approval process drug-device manufacturers
    Acorn Regulatory, an ISO-certified medical device and pharmaceutical consulting firm, is streamlining procedures for U.S. manufacturers of drug-device combinations with customized programs that successfully overcome challenges in meeting European regulatory approvals. Focusing on small to mid-size companies, Acorn Regulatory has put in place a comprehensive step-by-step process that provides the correct regulatory pathway for medical […]
  • Athermal laser machining cuts bioabsorbable polymers and more
    A the recent MD&M East trade show in New York, Norman Noble, discussed the capability of athermal laser manufacturer. The company has developed the Noble S.T.E.A.L.T.H. (System To Enable Ablation Laser Technology Haz-free). The athermal laser machining process was developed to create precise features in any material, including bioabsorbable polymers, shape memory metals and other […]
  • Exciting possibilities for metallic glass in the medical device world
    Researchers are exploring the potential of metallic glass as a versatile, pliable material that is stronger than steel, with a bevy of possible medical device applications. Yale University engineers have discovered a unique method for designing metallic glass nanostructures across a wide range of chemicals, a technique that could have applications for everything from watch […]
  • Strong Precision Technologies’ medical divisions to unify under MedTorque brand
    Strong Precision Technologies announced on July 2, 2015, that its two medical divisions will now go to market under a single brand, MedTorque. The move reflects the increasing integration of the division formerly known as Inland Midwest with MedTorque, its sister division in Kenosha, WI. “We will continue providing our customers with the personalized level of service […]
  • Olympus offers next-day product replacement guarantee for medical devices
    Olympus, a medical and surgical procedures solutions company, announced that it is guaranteeing next-day replacements for surgical equipment at no additional charge. Olympus is the first surgical product manufacturer to offer this type of guarantee. The service became available to customers with an Olympus Full Service Agreement earlier this year. “Canceled procedures can be costly for healthcare facilities […]
  • More accurate prediction on prognosis in multiple myeloma from SkylineDx
    SkylineDx, a biotechnology company specializing in the development and commercialization of genetic tests, is launching its MMprofiler assay. This test enables clinicians to more accurately predict the prognosis of patients with multiple myeloma (bone marrow cancer) than traditional methods. The MMprofiler measures the activity of 92 genes which are directly or indirectly related to the […]

Leave a Reply